Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
InnoCan Pharma: Jetzt in die Doppel-Chance investieren?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CVR6 | ISIN: FR00140048X2 | Ticker-Symbol: 9W8
Frankfurt
23.05.24
08:05 Uhr
1,400 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IKONISYS Chart 1 Jahr
5-Tage-Chart
IKONISYS 5-Tage-Chart

Aktuelle News zur IKONISYS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiIkonisys: Hospitex Expands in Ukraine through a Partnership with Diagen LLC to Fight Cancer179Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis...
► Artikel lesen
15.05.Ikonisys SA: Ikonisys: Hospitex to Obtain International Patent for the BLOCKfast Cyto-Inclusion Kit191Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis...
► Artikel lesen
30.04.Ikonisys SA: Ikonisys Announces the Postponement of the Publication of Its Annual Financial Report252Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 Ticker: ALIKO) (Paris:ALIKO), a company specializing in the early and accurate detection of cancer with a unique and fully-automated solution...
► Artikel lesen
29.02.Ikonisys SA: Ikonisys: Hospitex International to Partner With Allianz Value for First Large-Scale Screening Program Dedicated to Urinary Tract Oncology Diagnostics in Italy356Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis...
► Artikel lesen
19.02.Ikonisys SA: Ikonisys Announces That Hospitex International Won the Public Tender of the Prestigious U.O.C. Pathological Anatomy of Ragusa307Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis...
► Artikel lesen
06.02.Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy183Original-Research: Ikonisys SA - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu Ikonisys SA Unternehmen: Ikonisys SA ISIN: FR00140048X2 Anlass der Studie: Update Report Empfehlung:...
► Artikel lesen
02.01.Ikonisys SA: Ikonisys: New Production Record for Hospitex International412Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis...
► Artikel lesen
28.12.23Ikonisys Announces the Completion of a Private Placement to Speed up Growth Following Recent Pivotal Deals568Private placement of €1m, conducted with a restricted group of Italian private and institutional investors Following recent announcements, these funds will enable Ikonisys to speed up growth...
► Artikel lesen
15.12.23Ikonisys SA: Ikonisys Announces a Partnership Between Hospitex International and the Pathologists Beyond Borders Association309Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis...
► Artikel lesen
30.11.23Ikonisys SA: Ikonisys to Acquire Hospitex International and Become an Integrated Cancer Diagnostic Leader361Hospitex, a world leader in Thin Layer Cytology and Cancer Diagnostics, providing a competitive solution based on a patented and cutting-edge technology, the Nephelometric Smart Technology (NST)...
► Artikel lesen
01.11.23Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy297Original-Research: Ikonisys SA - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu Ikonisys SA Unternehmen: Ikonisys SA ISIN: FR00140048X2 Anlass der Studie: Update Report Empfehlung:...
► Artikel lesen
31.10.23Ikonisys SA: Ikonisys and Biocare Medical Forge Alliance: Amplifying Global FISH Diagnostics with Advanced Fluorescent Scopes350Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 Ticker: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical diagnostic...
► Artikel lesen
30.10.23Ikonisys SA: Ikonisys publishes its 2023 half-year financial results and reviews its operational and strategic deployments282Expansion of the market outside of the US and Europe and beginning of the commercialization of the high-volume system, Ikoniscope20max: Signing of a Distribution Collaboration with Integrated...
► Artikel lesen
16.10.23Ikonisys Successfully Completed Its ISO Certification Reaffirming Its Ability to Continuously Meet Quality International Standard Requirements328Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 Ticker: ALIKO) (Paris:ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution...
► Artikel lesen
10.10.23Ikonisys SA: Successful Study in Collaboration With the Neag Cancer Center of UConn School of Medicine Demonstrates the Power of the Ikoniscope Platform for Detection of Extremely Rare Cells in the Field of Immuno-Oncology383Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 Ticker: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical diagnostic...
► Artikel lesen
03.08.23Ikonisys Announces the Completion of New Financing via the Issuance of a €0.5m Private Note525Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical...
► Artikel lesen
31.07.23Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy3.048Original-Research: Ikonisys SA - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu Ikonisys SA Unternehmen: Ikonisys SA ISIN: FR00140048X2 Anlass der Studie: Update Report Empfehlung:...
► Artikel lesen
31.07.23Ikonisys SA: Ikonisys presents an update of its global activity in the context of its recent technological and commercial milestones374Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical...
► Artikel lesen
28.07.23Ikonisys SA: Ikonisys Announces the Successful Deployment of the Commercial Strategy With the Second Sale of the Ikoniscope20max Solution716Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical...
► Artikel lesen
26.07.23Ikonisys SA: Half-Yearly Report on the Ikonisys Liquidity Contract at 30/06/2023428Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO For the liquidity contract signed by Ikonisys with Invest Securities, the following means were included in the liquidity...
► Artikel lesen
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1